Finance

Lists
Why is BHC up २.६९%?
Dive Deeper
BHC:NYSE
Bausch Health Companies Inc
US$ ८.४०
+२.६९%
(+०.२२) 1D
US$ ८.४०
०.००% (०.००)
After hours
Closed: नोभेम्बर ९, १६:००:०२ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BHC...
Open
US$ ८.१९
High
US$ ८.५६
Low
US$ ८.१९
Mkt. cap
३.१७ अरब
Avg. vol.
३६.७४ लाख
Volume
३९.५२ लाख
52-wk high
US$ ९.०४
52-wk low
US$ ४.३३
EPS
-US$ २.२९
Beta
०.३०
Shares outstanding
३७.४३ करोड
No. of employees
२० हजार
Open
US$ ८.१९
High
US$ ८.५६
Low
US$ ८.१९
Mkt. cap
३.१७ अरब
Avg. vol.
३६.७४ लाख
Volume
३९.५२ लाख
52-wk high
US$ ९.०४
52-wk low
US$ ४.३३
EPS
-US$ २.२९
Beta
०.३०
Shares outstanding
३७.४३ करोड
No. of employees
२० हजार
News stories
From web sources and news partners
Bloomberg.com
Bloomberg.com
·
६ घण्टा पहिले
Watch S&P 500 Erases Midterm Losses, Bitcoin Bounce
ChartMill
ChartMill
·
९ घण्टा पहिले
Most-Active S&P 500 Stocks in Today's Session
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees२०.३ हजार
Founded१९६०
Headquartersलाभाल, क्युबेक, क्यानाडा
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to BHC in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for BHC in the last 3 months.
Highest
Current US$ ८.४०
US$ १०.०० (+१९.०५%)
Average
US$ ८.३३ (-०.८३%)
Lowest
US$ ७.०० (-१६.६७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Young Li
Jefferies
Hold
Reiterated
US$ ८.००
-४.८%
10/29/2026
Douglas Miehm
RBC Capital
Hold
Reiterated
US$ १०.००
+१९%
10/29/2026
Glen Santangelo
Barclays
Hold
Maintained
US$ ७.००
-१६.७%
10/29/2026
Les Sulewski
Truist Financial
Hold
Reiterated
-
-
05/01/2026
Michael Nedelcovych
TD Cowen
Hold
Maintained
US$ ७.००
-१६.७%
04/30/2026
Umer Raffat
Evercore ISI
Hold
Maintained
-
-
04/30/2026
Jason Gerberry
Bank of America Securities
Sell
Reiterated
US$ ५.००
-४०.५%
02/18/2026
Last report
२०२६ अक्टोबर २८
Fiscal period
Q3 2026
US$ १.७७ / US$ १.२४
+४२.४५%beat
Revenue / Est. (USD)
२.९४ अरब / २.७५ अरब
+६.७६%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
२.८० अरब
२.५२ अरब
२.८५ अरब
२.९४ अरब
Cost of goods sold
७९.८० करोड
७३.८० करोड
७७.२० करोड
७३.५० करोड
Cost of revenue
७९.८० करोड
७३.८० करोड
७७.२० करोड
७३.५० करोड
Research and development expenses
१६.१० करोड
१६.३० करोड
१७.३० करोड
१४.१० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८८.०० करोड
८६.०० करोड
९०.७० करोड
८३.४० करोड
Operating expense
१.२८ अरब
१.२६ अरब
१.३० अरब
१.२० अरब
Total operating expenses
२.०८ अरब
२.०० अरब
२.०८ अरब
१.९४ अरब
Operating income
७२.१० करोड
५२.१० करोड
७७.५० करोड
१.०१ अरब
Other non operating income
-
-
-
-
EBT including unusual items
५.६० करोड
-१.३५ अरब
३४.८० करोड
५९.७० करोड
EBT excluding unusual items
३२.२० करोड
११.८० करोड
३८.३० करोड
६२.०० करोड
Income tax expense
१५.९० करोड
७.७० करोड
८.८० करोड
१५.१० करोड
Effective tax rate
२८३.९३%
-५.६९%
२५.२९%
२५.२९%
Other operating expenses
-
१०.०० लाख
-
-२०.०० लाख
Net income
-११.२० करोड
-१.४२ अरब
२५.८० करोड
४३.६० करोड
Net profit margin
-४.०१%
-५६.३८%
९.०५%
१४.८२%
Earnings per share
१.१०
०.७८
१.२६
१.७७
Interest and investment income
९०.०० लाख
१.०० करोड
१.१० करोड
१.३० करोड
Interest expense
-३९.७० करोड
-४०.२० करोड
-३९.६० करोड
-३९.८० करोड
Net interest expenses
-३८.८० करोड
-३९.२० करोड
-३८.५० करोड
-३८.५० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.०१ अरब
८१.६० करोड
१.०६ अरब
१.२९ अरब
Gain or loss from assets sale
-
-३०.०० लाख
-
-१०.०० लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू